These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 33395258)
21. Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease. Wu M; Ma J; Ji L; Wang M; Han J; Li Z Eur J Med Chem; 2019 Sep; 177():198-211. PubMed ID: 31136894 [TBL] [Abstract][Full Text] [Related]
23. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease. El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors. Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217 [TBL] [Abstract][Full Text] [Related]
25. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents. Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease. Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946 [TBL] [Abstract][Full Text] [Related]
27. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease. Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents. El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents. Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835 [TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer's Agents. Panek D; Więckowska A; Jończyk J; Godyń J; Bajda M; Wichur T; Pasieka A; Knez D; Pišlar A; Korabecny J; Soukup O; Sepsova V; Sabaté R; Kos J; Gobec S; Malawska B ACS Chem Neurosci; 2018 May; 9(5):1074-1094. PubMed ID: 29345897 [TBL] [Abstract][Full Text] [Related]
33. Ethyl nitrobenzoate: A novel scaffold for cholinesterase inhibition. Yeong KY; Liew WL; Murugaiyah V; Ang CW; Osman H; Tan SC Bioorg Chem; 2017 Feb; 70():27-33. PubMed ID: 27863748 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744 [TBL] [Abstract][Full Text] [Related]
35. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393 [TBL] [Abstract][Full Text] [Related]
36. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening. Liu G; Jiao Y; Lin Y; Hao H; Dou Y; Yang J; Jiang CS; Chang P Chem Pharm Bull (Tokyo); 2020 Feb; 68(2):161-166. PubMed ID: 31813907 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845 [TBL] [Abstract][Full Text] [Related]
38. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease. de Almeida JR; Figueiro M; Almeida WP; de Paula da Silva CHT Future Med Chem; 2018 May; 10(9):1037-1053. PubMed ID: 29676170 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin. Yan J; Hu J; Liu A; He L; Li X; Wei H Bioorg Med Chem; 2017 Jun; 25(12):2946-2955. PubMed ID: 28454848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]